Manufacturer:

Janssen

Name:

Rybrevant

Category:

J Code

HCPCS:

J9061

NDC(s):

57894-0501-01,

Primary Type:

Cancer

Route of Administration:

Intravenous

About:

Rybrevant is a Cancer drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J9061 is aligned to the drug Rybrevant.